Epogen

Bristol Myers data make case for earlier use of bone marrow disease drug
Bristol Myers data make case for earlier use of bone marrow disease drug
BioPharma Dive
Bristol Myers Squibb
Reblozyl
Epogen
myelodysplastic syndromes
clinical trials
Flag link:
Pfizer launches biosimilar version of Amgen's Epogen
Pfizer launches biosimilar version of Amgen's Epogen
Biopharma Dive
Pfizer
biosimilars
Amgen
Epogen
JNJ
Procrit
anemia
Flag link:
Pfizer’s Epoetin Alfa Biosimilar Approved by FDA
Pfizer’s Epoetin Alfa Biosimilar Approved by FDA
RAPS.org
FDA
Amgen
biosimilars
Epogen
epoetin alfa
Retacrit
Pfizer
Flag link:
What to Expect From Amgen, Inc. in 2018
What to Expect From Amgen, Inc. in 2018
Motley Fool
Amgen
Enbrel
Neulasta
Aranesp
Epogen
Neupogen
Prolia
Repatha
CAR-T
Flag link:
Will 2018 Be Amgen Inc.'s Best Year Yet?
Will 2018 Be Amgen Inc.'s Best Year Yet?
Motley Fool
Amgen
Enbrel
Aranesp
Neulasta
Epogen
Flag link:
The 2018 biosimilar litigation landscape: A primer
The 2018 biosimilar litigation landscape: A primer
BioPharma Dive
biosimilars
FDA
Neupogen
Neulasta
Remicade
Epogen
Enbreal
Humira
Avastin
Herceptin
Flag link:
Amgen falls short in Epogen patent appeal but Pfizer stumble delays competition
Amgen falls short in Epogen patent appeal but Pfizer stumble delays competition
Fierce Pharma
Amgen
Epogen
patents
Pfizer
anemia
biosimilars
Flag link:
FDA Rejects Pfizer's Anemia Drug Biosimilar
FDA Rejects Pfizer's Anemia Drug Biosimilar
Xtalks
FDA
Pfizer
biosimilars
Epogen
Amgen
anemia
Flag link:
FDA rejects Pfizer's Epogen biosimilar for the second time
FDA rejects Pfizer's Epogen biosimilar for the second time
Fierce Pharma
FDA
Pfizer
biosimilars
Epogen
Flag link:
FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson
FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson
Fierce Pharma
FDA
advisory panels
Pfizer
biosimilars
Amgen
Epogen
Procrit
anemia
JNJ
Flag link:
Pfizer's Epogen biosim scores solid backing from FDA staff ahead of panel review
Pfizer's Epogen biosim scores solid backing from FDA staff ahead of panel review
Fierce Pharma
Pfizer
Epogen
biosimilars
FDA
advisory panels
Amgen
anemia
Flag link:
Amgen Inc to Face Off Pfizer & Novartis to Save Key Drugs
Amgen Inc to Face Off Pfizer & Novartis to Save Key Drugs
Bidness, ETC
Amgen
Pfizer
Novartis
Enbrel
Epogen
Flag link:
Amgen's Innovation Counters Biosimilar Pressure
Amgen's Innovation Counters Biosimilar Pressure
Morningstar
Amgen
innovation
biosimilars
Epogen
Aranesp
Neupogen
Flag link:
Amgen Wants Patent Dance Redo and a Halt to Hospira’s EPOGEN Biosimilar
Amgen Wants Patent Dance Redo and a Halt to Hospira’s EPOGEN Biosimilar
FDA Law Blog
Amgen
patents
Hospira
biosimilars
Epogen
Flag link:
Can Sprout's Addyi shrug off serious side effects? These blockbusters did
Can Sprout's Addyi shrug off serious side effects? These blockbusters did
Fierce Pharma Marketing
Sprout Pharmaceuticals
Addyi
female sexual dysfunction
side effects
Advair
GSK
Amgen
Epogen
Merck
Fosamax
Flag link:
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Fierce Pharma Marketing
biosimilars
AbbVie
Roche
Amgen
Rituxan
Herceptin
Avastin
Neupogen
Neulasta
Epogen
Humira
Perjeta
Gazyva
Flag link:
Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
Fierce Pharma
Amgen
Epogen
anemia
Procrit
JNJ
Flag link:
Generic Threats To Amgen's Biologics
Generic Threats To Amgen's Biologics
Seeking Alpha
Amgen
generics
biosimilars
Neupogen
Aranesp
Epogen
Flag link:
[video]3 Amgen Biologics Facing Generic Competition
[video]3 Amgen Biologics Facing Generic Competition
Motley Fool
Amgen
generics
Aranesp
Epogen
Neupogen
Flag link:
EPO Pills: A Challenge For Amgen And Johnson & Johnson
EPO Pills: A Challenge For Amgen And Johnson & Johnson
Seeking Alpha
JNJ
Amgen
Aranesp
Procrit
Epogen
Flag link:

Pages